Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection

Overview of attention for article published in Frontiers in Pharmacology, November 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,845 followers.

RT @FrontPharmacol: New Research: Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infect…

11 Nov 2022

Reply Repost Favourite

New Research: Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection https://t.co/fUDGXyZEIn #pharmacology

11 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.